Sifflet | $18,000,000 | (Jun 24, 2025)
RevelAi Health | $3,100,000 | (Jun 24, 2025)
SWARM Biotactics | $11,591,050 | (Jun 24, 2025)
Certified by Founder
Lodge
T-Therapeutics Ltd
start up
United Kingdom
- Cambridge
- 16/11/2023
- Series A
- $59,707,000
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs.
We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
- Industry Biotechnology Research
- Website https://t-therapeutics.com/
- LinkedIn https://www.linkedin.com/company/t-therapeutics/about/
Veda | $18,000,000 | (Jun 24, 2025)
Meridian | $7,000,000 | (Jun 24, 2025)
Spinwheel | $30,000,000 | (Jun 24, 2025)
Stackup | $4,200,000 | (Jun 24, 2025)
VoiceCare AI | $4,500,000 | (Jun 24, 2025)
YieldClub | $2,500,000 | (Jun 24, 2025)
Steuerboard | $841,106,314 | (Jun 24, 2025)
Botpress | $25,000,000 | (Jun 24, 2025)
Snowcap Compute Inc. | $23,000,000 | (Jun 24, 2025)
Profound | $20,000,000 | (Jun 24, 2025)